Table 4.
Comparison of apoptosis of MGCs, CCs, and FF hormones in different age groups
| Parameters | < 30 (n = 64) | 30–37 (n = 70) | ≥ 37 (n = 30) | P value |
|---|---|---|---|---|
| MGCs necrosis rate (%) | 5.33(1.00–15.40)) | 3.51 (0.55–10.29) | 3.61 (0.75–8.40) | ns |
| MGCs early apoptosis rate (%) | 0.45 (0.20–1.00) | 0.62 (0.25–1.46) | 1.30 (0.535–2.40) | < 0.0001 |
| MGCs late apoptosis rate (%) | 2.08 (0.29–5.67) | 2.26 (0.42–4.81) | 6.40 (2.33–15.70) | < 0.05 |
| MGCs total apoptosis rate (%) | 2.85 (0.83–6.42) | 2.77 (1.00–6.69) | 6.91 (3.92–17.05) | < 0.0005 |
| CCs necrosis rate (%) | 1.24 (0.20–2.01) | 0.49 (0.06–1.70) | 1.07 (0.44–2.17) | ns |
| CCs early apoptosis rate (%) | 0.21 (0.04–0.66) | 0.31 (0.10–1.06) | 0.30 (0.20–1.03) | ns |
| CCs late apoptosis rate (%) | 4.46 (0.78–13.75) | 5.83 (0.72–11.8) | 5.76 (2.65–10.52) | ns |
| CCs total apoptosis rate (%) | 5.60 (1.77–15.00) | 6.79 (1.44–12.18) | 6.80 (3.07–10.90) | ns |
| FF AMH (ng/mL) | 3.66 (2.33–6.22) | 2.57 (1.44–4.30) | 1.77 (0.80–2.66) | < 0.05 |
| FF E2 (pmol/L) | 692,885 (491,558–988,625) | 618,862 (470,400–893,500) | 816,500 (615,000–1,157,250) | ns |
| FF P4 (ng/mL) | 21,010 (14,100–46,000) | 15,000 (12,000–29,990) | 14,400 (9750–17,100) | ns |
| FF T (nmol/L) | 5.80 (4.27–8.66) | 5.18 (3.99–11.85) | 5.99 (3.63–8.34) | ns |
All parameters were shown as median (interquartile range (IQR)). P < 0.05 (two-sided) was considered statistically significant, Kruskal-Wallis H test was used